These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7887368)

  • 1. OTC switch considered for asthma.
    Am Pharm; 1995 Jan; NS35(1):10. PubMed ID: 7887368
    [No Abstract]   [Full Text] [Related]  

  • 2. Making the most of the Rx-OTC switch. An interview with Charles A. Pergola [by John Covert].
    Pergola CA
    Am Pharm; 1984 Feb; NS24(2):34-8. PubMed ID: 6702589
    [No Abstract]   [Full Text] [Related]  

  • 3. Rx-to-OTC shift: not for these widely used drugs.
    Chase SL
    RN; 1995 Jan; 58(1):67. PubMed ID: 7624708
    [No Abstract]   [Full Text] [Related]  

  • 4. Rx drugs switched to OTC.
    FDA Drug Bull; 1983 Nov; 13(3):29-30. PubMed ID: 6653955
    [No Abstract]   [Full Text] [Related]  

  • 5. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.
    Spencer HM
    Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546
    [No Abstract]   [Full Text] [Related]  

  • 6. OTC interactions. Asthma medications.
    Rodman MJ
    RN; 1993 Apr; 56(4):40-5. PubMed ID: 8480129
    [No Abstract]   [Full Text] [Related]  

  • 7. The debate continues on OTC switches.
    Giaquinta D
    Manag Care Interface; 2003 Jun; 16(6):49-50. PubMed ID: 12841076
    [No Abstract]   [Full Text] [Related]  

  • 8. The American College of Allergists and the Food and Drug Administration.
    Boggs PB
    Ann Allergy; 1986 Jun; 56(6):443. PubMed ID: 3717709
    [No Abstract]   [Full Text] [Related]  

  • 9. Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition.
    Kraushaar KJ
    Food Drug Law J; 1999; 54(2):243-4. PubMed ID: 11758581
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription to over-the-counter drug switches.
    Rheinstein PH
    Am Fam Physician; 1997 Sep; 56(4):1211-4. PubMed ID: 9310067
    [No Abstract]   [Full Text] [Related]  

  • 11. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?
    Shiffman S; Sweeney CT
    Health Policy; 2008 Apr; 86(1):17-26. PubMed ID: 17935827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No doctor required. The FDA may expand the number of prescription drugs it converts to over-the-counter use.
    Thompson M
    Time; 2000 Jul; 156(3):38. PubMed ID: 11009720
    [No Abstract]   [Full Text] [Related]  

  • 13. Steps taken to lessen tampering with OTC drugs.
    FDA Drug Bull; 1983 Apr; 13(1):6. PubMed ID: 6852409
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
    Sullivan PW; Nair KV; Patel BV
    Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic aspects of drug over use.
    Rucker TD
    Med Ann Dist Columbia; 1973 Dec; 42(12):609-14. PubMed ID: 4520521
    [No Abstract]   [Full Text] [Related]  

  • 16. Abuse of OTC medications, prescription drugs raises concern.
    Langford RE
    Occup Health Saf; 2001 Dec; 70(12):8. PubMed ID: 11799566
    [No Abstract]   [Full Text] [Related]  

  • 17. Advisory committees; OTC Drugs Advisory Committee; establishment--FDA. Final rule.
    Fed Regist; 1991 Sep; 56(185):48103-4. PubMed ID: 10114368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional criteria and procedures for classifying over-the-counter drugs as generally recognized as safe and effective and not misbranded. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jan; 67(15):3060-76. PubMed ID: 11820251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-OTC marketing of drugs: possible approaches.
    Mahinka SP; Bierman ME
    Food Drug Law J; 1995; 50(1):49-63. PubMed ID: 10342985
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA considers OTC drug labeling reform.
    Am Pharm; 1995 Nov; NS35(11):5-6. PubMed ID: 8533722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.